Floatz logo

Folic Acid

Essential Hypertension

Shenzhen Ausa Pharmed Co.,LtdSmall moleculePhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Essential Hypertension cohort.

Asset / SponsorPhaseRating
AMLODIPINE
Yuhan Corporation
Phase 4BBB
LEVAMLODIPINE
Chong Kun Dang Pharmaceutical
Phase 4BB
Chlorthalidone
Yuhan Corporation
Phase 4BB
Micardis®
Yuhan Corporation
Phase 4B
Hydrochlorothiazide
Daiichi Sankyo
Phase 3B

View all 9 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →